272 related articles for article (PubMed ID: 33791233)
41. Neutrophil-to-lymphocyte ratio and lactate dehydrogenase for early diagnosis of AIDS patients with Talaromyces marneffei infection.
Huang JL; Zhou XX; Luo P; Lu XY; Liang LH; Lan GB; Chen L; Lin FQ
Ann Palliat Med; 2022 Feb; 11(2):588-597. PubMed ID: 35249337
[TBL] [Abstract][Full Text] [Related]
42. Clinical characteristics of tracheobronchial
Pan M; Fang G; Zheng F; Lin F; Zeng W; Qiu Y; Deng J; Chen X; Zhang J
Ann Med; 2023; 55(2):2276310. PubMed ID: 37967226
[TBL] [Abstract][Full Text] [Related]
43. Serum Sphingolipids Aiding the Diagnosis of Adult HIV-Negative Patients with
Li ZT; Yau LF; Qiu Y; Li SQ; Zhan YQ; Chan WH; Chen ZM; Li Z; Li Y; Lin Y; Cheng J; Zhang JQ; Jiang ZH; Wang JR; Ye F
Front Cell Infect Microbiol; 2021; 11():701913. PubMed ID: 34262882
[TBL] [Abstract][Full Text] [Related]
44. A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Zeng W; Qiu Y; Lu D; Zhang J; Zhong X; Liu G
Medicine (Baltimore); 2015 Aug; 94(34):e1439. PubMed ID: 26313802
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains.
Peng L; Shi YB; Zheng L; Hu LQ; Weng XB
J Clin Lab Anal; 2022 Nov; 36(11):e24737. PubMed ID: 36268985
[TBL] [Abstract][Full Text] [Related]
46. Successful voriconazole treatment of Talaromyces marneffei infection in an HIV-negative patient with osteolytic lesions.
Ge Y; Xu Z; Hu Y; Huang M
J Infect Chemother; 2019 Mar; 25(3):204-207. PubMed ID: 30195473
[TBL] [Abstract][Full Text] [Related]
47. Fatal Talaromyces marneffei Infection in a Patient with Autoimmune Hepatitis.
Wong SCY; Sridhar S; Ngan AHY; Chen JHK; Poon RWS; Lau SKP; Woo PCY
Mycopathologia; 2018 Jun; 183(3):615-618. PubMed ID: 29349620
[TBL] [Abstract][Full Text] [Related]
48. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.
Chan JF; Lau SK; Yuen KY; Woo PC
Emerg Microbes Infect; 2016 Mar; 5(3):e19. PubMed ID: 26956447
[TBL] [Abstract][Full Text] [Related]
49. Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review.
Gao Y; Qu M; Song C; Yin L; Zhang M
J Neurovirol; 2022 Apr; 28(2):274-280. PubMed ID: 34981436
[TBL] [Abstract][Full Text] [Related]
50. Talaromyces marneffei infection relapse presenting as osteolytic destruction followed by suspected nontuberculous mycobacterium infection during 6 years of follow-up: A case update.
Liang X; Si L; Li Y; Zhang J; Deng J; Bai J; Li M; He Z
Int J Infect Dis; 2020 Apr; 93():208-210. PubMed ID: 32105768
[TBL] [Abstract][Full Text] [Related]
51. Disseminated Talaromyces marneffei and Mycobacterium intracellulare coinfection in an HIV-infected patient.
Seok H; Ko JH; Shin I; Eun YH; Lee SE; Lee YB; Peck KR
Int J Infect Dis; 2015 Sep; 38():86-8. PubMed ID: 26232630
[TBL] [Abstract][Full Text] [Related]
52. Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.
Wang P; Chen Y; Xu H; Ding L; Wu Z; Xu Z; Wang K
Mycopathologia; 2017 Aug; 182(7-8):751-754. PubMed ID: 28349349
[TBL] [Abstract][Full Text] [Related]
53. Mindray BC-6900 Scattergram Analysis Combined with Peripheral Blood Smear in the Diagnosis of T. Marneffei Infection in an HIV-Positive Patient: a Case Report.
Huang W; Lu Z; Wu L; Luo W; Liang S; Feng J; Liu X; Su Q; Chen J; Liu C; Sun Y
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616342
[TBL] [Abstract][Full Text] [Related]
54. A mass in the upper abdomen derived from Talaromyces marneffei infected lymphadenopathy: a case report.
Chen X; Jia L; Wu Y; Chang J; Zhang T; Ma Y; Zhang Y
BMC Infect Dis; 2021 Aug; 21(1):750. PubMed ID: 34348692
[TBL] [Abstract][Full Text] [Related]
55. Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with
Chen ZM; Yang XY; Li ZT; Guan WJ; Qiu Y; Li SQ; Zhan YQ; Lei ZY; Liu J; Zhang JQ; Wang ZF; Ye F
Infect Drug Resist; 2022; 15():3381-3393. PubMed ID: 35789796
[TBL] [Abstract][Full Text] [Related]
56. Novel Partitivirus Enhances Virulence of and Causes Aberrant Gene Expression in Talaromyces marneffei.
Lau SKP; Lo GCS; Chow FWN; Fan RYY; Cai JJ; Yuen KY; Woo PCY
mBio; 2018 Jun; 9(3):. PubMed ID: 29895639
[No Abstract] [Full Text] [Related]
57. Nodular Sclerosing Hodgkin Lymphoma Combined with Disseminated
Yang Z; Zeng W; Qiu Y; Liu G; Zhang J
Infect Drug Resist; 2021; 14():5671-5678. PubMed ID: 34992393
[TBL] [Abstract][Full Text] [Related]
58. Determinants of prognosis in Talaromyces marneffei infections with respiratory system lesions.
Qiu Y; Zhang JQ; Pan ML; Zeng W; Tang SD; Tan CM
Chin Med J (Engl); 2019 Aug; 132(16):1909-1918. PubMed ID: 31348027
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of quantitative real-time PCR and Platelia galactomannan assays for the diagnosis of disseminated Talaromyces marneffei infection.
Li X; Zheng Y; Wu F; Mo D; Liang G; Yan R; Khader JA; Wu N; Cao C
Med Mycol; 2020 Feb; 58(2):181-186. PubMed ID: 31131856
[TBL] [Abstract][Full Text] [Related]
60. Successful treatment of Talaromyces marneffei pneumonia in a HIV-negative renal transplantation recipient: A case report.
Cai DH; Wang J; Fang XL
Medicine (Baltimore); 2022 Oct; 101(40):e30958. PubMed ID: 36221387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
